TOMBERLI, ALESSIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 819
NA - Nord America 819
AS - Asia 233
AF - Africa 3
SA - Sud America 1
Totale 1.875
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 819
RU - Federazione Russa 401
IT - Italia 136
IE - Irlanda 78
PL - Polonia 76
SE - Svezia 68
SG - Singapore 66
HK - Hong Kong 57
CN - Cina 44
IN - India 28
JO - Giordania 22
DE - Germania 15
CH - Svizzera 14
VN - Vietnam 9
GB - Regno Unito 8
FI - Finlandia 7
RS - Serbia 5
NL - Olanda 4
PH - Filippine 4
CI - Costa d'Avorio 3
ES - Italia 2
KR - Corea 2
UA - Ucraina 2
BE - Belgio 1
CL - Cile 1
FR - Francia 1
JP - Giappone 1
PT - Portogallo 1
Totale 1.875
Salva come PNG Salva come JPEG
Città #
Santa Clara 206
Dublin 78
Chandler 77
Warsaw 73
Fairfield 70
Singapore 57
Ashburn 53
Hong Kong 42
Moscow 36
Florence 34
Seattle 32
Cambridge 29
Houston 29
Woodbridge 29
New York 26
Wilmington 26
Lawrence 24
Mumbai 23
Altamura 21
Buffalo 15
Princeton 15
Beijing 14
Bern 14
Shanghai 14
Boston 11
Munich 10
Naples 10
Prato 9
Dong Ket 8
Milan 8
Kent 7
Medford 7
Ann Arbor 6
Boardman 6
San Diego 6
Belgrade 5
Helsinki 5
Abidjan 3
Hillsboro 3
Quezon City 3
Siena 3
Andover 2
Anghiari 2
Cervia 2
Chennai 2
Duncan 2
Falls Church 2
Gubbio 2
Lappeenranta 2
Lecce 2
Livorno 2
Los Angeles 2
Norwalk 2
Pontedera 2
Salerno 2
Seoul 2
Torremolinos 2
Vellore 2
Vicenza 2
Wandsworth 2
Yubileyny 2
Amsterdam 1
Anguillara Sabazia 1
Bari 1
Breendonk 1
Bruino 1
Changsha 1
Clifton 1
Genova 1
Grafing 1
Hanoi 1
Jinhua 1
Kilburn 1
London 1
Mem Martins 1
Nanjing 1
Palermo 1
Pavia 1
Prescot 1
Pune 1
Rome 1
San Miniato Basso 1
Santa Maria 1
Santiago 1
Sapporo 1
Scuola 1
Sestri Levante 1
Southwark 1
Staranzano 1
Tavarnuzze 1
Washington 1
Wuhan 1
Totale 1.218
Salva come PNG Salva come JPEG
Nome #
Defining the diagnostic effectiveness of genes for inclusion in panels: the experience of two decades of genetic testing for hypertrophic cardiomyopathy at a single center 185
Long-term Outcomes of Pediatric-Onset Hypertrophic Cardiomyopathy and Age-Specific Risk Factors for Lethal Arrhythmic Events 132
Timing of invasive septal reduction therapies and outcome of patients with obstructive hypertrophic cardiomyopathy 107
Design of the SILICOFCM study: Effect of sacubitril/valsartan vs lifestyle intervention on functional capacity in patients with hypertrophic cardiomyopathy 107
Cardiac involvement in eosinophilic granulomatosis with polyangiitis (formerly Churg-Strauss syndrome): Prospective evaluation at a tertiary referral centre 107
Comprehensive Risk Management in Arrhythmogenic Cardiomyopathy Associated With Autosomal Dominant Carvajal Syndrome 99
Doctor-patient care relationship in genetic cardiomyopathies: An exploratory study on clinical consultations 96
Prevalence, causes and predictors of cardiovascular hospitalization in patients with hypertrophic cardiomyopathy 96
Myocardial blood flow in patients with hypertrophic cardiomyopathy receiving perindopril (CARAPaCE): a pilot study 92
Red flags for the diagnosis of cardiac amyloidosis: Simple suggestions to raise suspicion and achieve earlier diagnosis 84
Efficacy and safety of dysopiramide in patients with obstructive hypertrophic cardiomyopathy 84
Targeted Medical Therapies for Hypertrophic Cardiomyopathy 80
Mavacamten, a Novel Therapeutic Strategy for Obstructive Hypertrophic Cardiomyopathy 69
Early Diagnosis and Outcome in Patients With Wild-Type Transthyretin Cardiac Amyloidosis 66
Genetic Testing and Counselling in Hypertrophic Cardiomyopathy: Frequently Asked Questions 61
Prognostic value of cardiopulmonary exercise testing in patients with transthyretin cardiac amyloidosis 60
Clinical course and outcome of pregnancy in patients with hypertrophic cardiomyopathy 57
Incidence of stroke in patients with hypertrophic cardiomyopathy in stable sinus rhythm during long-term monitoring 53
Prevalence of anxiety and depression symptoms in a sample of outpatients with ATTR cardiac amyloidosis 51
Safety and efficacy of ranolazine in hypertrophic cardiomyopathy: Real-world experience in a National Referral Center 50
Sex-related differences in clinical presentation and all-cause mortality in patients with cardiac transthyretin amyloidosis and light chain amyloidosis 50
Arrhythmic Burden in Cardiac Amyloidosis: What We Know and What We Do Not 47
Real-World Use and Predictors of Response to Disopyramide in Patients with Obstructive Hypertrophic Cardiomyopathy 41
Impact of Pregnancy on the Natural History of Women with Hypertrophic Cardiomyopathy 37
Totale 1.911
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.336
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.336
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202099 0 0 0 0 14 15 14 15 15 8 18 0
2020/2021206 14 4 10 29 10 11 20 14 21 45 16 12
2021/2022122 5 1 7 3 4 15 4 4 17 10 25 27
2022/2023399 27 85 18 24 26 57 57 22 42 10 13 18
2023/2024255 8 23 24 11 14 41 19 61 8 24 14 8
2024/2025781 60 135 78 225 283 0 0 0 0 0 0 0
Totale 1.911